Waruni Abeysekera

443 citations
11 papers · 291 indexed · h-index 7
Topics
Immunotherapy and Immune Responses (2 papers)Genetics and Neurodevelopmental Disorders (2 papers)Epigenetics and DNA Methylation (2 papers)

In The Last Decade

Waruni Abeysekera

11 papers receiving 289 citations

Peers

Waruni Abeysekera
Comparison fields: 5 of 50
  • Molecular Biology 181
  • Immunology 108
  • Cancer Research 101
  • Oncology 63
  • Cell Biology 23
Replace Tzu-Sheng Hsu with:
Tzu-Sheng Hsu Taiwan
Yu‐Wen Su Taiwan
Silke E. Lindner Austria
Leona Rohrbeck Australia
Bárbara Peixoto Brazil
Lisanne M. Spilgies Switzerland
Ana I. Oliveira Portugal
Alexandros P. Drainas United States
Gabrielle E. Ciotti United States
Waruni Abeysekera relative to Tzu-Sheng Hsu Taiwan Tzu-Sheng Hsu's profile →
Citations per field
00.5×
Tzu-Sheng Hsu · 1×
Citations per year

Countries citing papers authored by Waruni Abeysekera

Since Specialization
Citations

This map shows the geographic impact of Waruni Abeysekera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waruni Abeysekera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waruni Abeysekera more than expected).

Fields of papers citing papers by Waruni Abeysekera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Waruni Abeysekera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waruni Abeysekera. The network helps show where Waruni Abeysekera may publish in the future.

Co-authorship network of co-authors of Waruni Abeysekera

This figure shows the co-authorship network connecting the top 25 collaborators of Waruni Abeysekera. A scholar is included among the top collaborators of Waruni Abeysekera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Waruni Abeysekera. Waruni Abeysekera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 1
2 8
3 4
4 2
5 10
6 115
7 5
8 6
9 44
10 8
11 88

About Waruni Abeysekera

Waruni Abeysekera is a scholar working on Immunology, Hematology and Cancer Research, having authored 11 papers that have together received 291 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (2 papers), Genetics and Neurodevelopmental Disorders (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (101 citations), Immunology (108 citations) and Molecular Biology (181 citations). Waruni Abeysekera has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Alexandra L. Garnham, Gordon K. Smyth, Ariena Kersbergen, Shalini Sethumadhavan, Dovile Anderson, Patrick M. Gubser, Axel Kallies, Joshua E. Goldford, Thomas P. Roddy and Sarah A. Best. Their work appears in journals such as The Journal of Experimental Medicine, Blood and Nature Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026